VS
Hamilton Healthcare Yield Maximizer ETF (LMAX) and Harvest Healthcare Leaders Income ETF (HHL) offer distinct profiles for Canadian ETF investors. A direct comparison shows that LMAX focuses its top 3 sector exposures on Healthcare and Consumer Non-Cyclicals, while HHL leans towards Healthcare and Sovereign. When evaluating costs, LMAX features a management fee (MER) of 0.65%, compared to 0.85% for HHL. Performance-wise, LMAX has returned 4.27% year-to-date with +$71 M in net flows, whereas HHL is at 0.84% with +$358 M. Use the comparison tool below to benchmark these funds across top 10 holdings, yield, sector weights and historical returns.
NAV Performance and Flows
Key Data
Compare
LMAX
HHL
| AuM | $225.59 M | $1,827.10 M |
| Management Fees | 0.65% | 0.85% |
| Exp. ratio | 0.80% | 0.98% |
| Tracking Difference | - | - |
Historical performance and flows
As of September 11, 2026
| 1M | 3M | YTD | 1Y | 3Y | ||
|---|---|---|---|---|---|---|
| Perf. | LMAX | -2.67% | +5.23% | +4.27% | +12.64% | - |
HHL | -3.81% | +5.43% | -0.84% | +7.83% | +18.09% | |
| Flows | LMAX | +$5 M | +$16 M | +$71 M | +$84 M | - |
HHL | +$4 M | +$45 M | +$358 M | +$359 M | +$691 M |
LMAX vs HHL exposure
Countries
LMAX
USA
95.96%
HHL
USA
84.21%
Other
15.79%
Sectors
LMAX
Healthcare
94.79%
HHL
Healthcare
98.89%
As of September 11, 2026
Top 10 Holdings
LMAX
AbbVie, Inc.
5.92%
CVS Health Corp.
5.89%
UnitedHealth Group, Inc.
5.86%
Eli Lilly & Co.
5.77%
Thermo Fisher Scientific, Inc.
5.75%
Bristol Myers Squibb Co.
5.50%
Amgen, Inc.
5.25%
Johnson & Johnson
5.21%
Merck & Co., Inc.
5.20%
Abbott Laboratories
5.09%
HHL
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%
Diversification
LMAX
Total weight of top 10 holdings out of 20 total
55.45%
HHL
Total weight of top 10 holdings out of 25 total
50.34%
Characteristics
Compare
LMAX
HHL
| Provider | Hamilton ETFs | Harvest Portfolios Group |
| Management | Actively managed | Actively managed |
| Benchmark | - | - |
| Replication Method | ||
| Asset Class | Equity | Equity |
| Dividend Policy | Distributing | Distributing |
| Trailing 12m distribution yield | 12.56% | 10.08% |
| Meets ESG criteria | No | No |
| Inception Date | February 6, 2024 | December 18, 2014 |
Frequently asked questions about LMAX and HHL
Which ETF has performed better year to date: LMAX or HHL?
As of September 11, 2026, LMAX has returned 4.27% year to date, while HHL has returned -0.84%. LMAX is ahead on YTD performance.
Which ETF is larger by assets under management: LMAX or HHL?
As of September 11, 2026, LMAX manages $225.59 M in assets, while HHL manages $1.83 B. HHL is the larger fund by AUM.
How are LMAX and HHL managed?
LMAX is actively managed by Hamilton ETFs. It does not track an index. HHL is actively managed by Harvest Portfolios Group. It does not track an index.
What sectors do LMAX and HHL emphasize?
LMAX is most exposed to Healthcare and Consumer Non-Cyclicals. HHL is most exposed to Healthcare and Sovereign.
Which ETF is attracting more investor flows: LMAX or HHL?
Year to date, LMAX has seen +$71.11 M in net flows, compared with +$357.74 M for HHL. HHL has attracted more net investor money so far.
How do the fees of LMAX and HHL compare?
LMAX has an expense ratio of 0.80%, while HHL has an expense ratio of 0.98%.
What are the top holdings of LMAX and HHL?
LMAX's largest holdings include AbbVie, Inc., CVS Health Corp., and UnitedHealth Group, Inc.. HHL's top holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp., and Bristol Myers Squibb Co..
Which ETF is more diversified: LMAX or HHL?
LMAX holds 20 securities, while HHL holds 25. On holdings count, HHL is the more diversified portfolio.
Recent articles about LMAX and HHL
Yield-focused ETFs and the Benefit They Can Provide Investors
ETFs that employ covered call-writing strategies can be effective ways to generate monthly yield for investors while still providing exposure to a security or asset class on a long-term basis.
Posted on 6/13/2024 by Kyle Anthony inStock Market
The ETF Market Canada is brought to you by Cboe in partnership with Trackinsight SA who is providing all the data, analysis and editorial content on this site. Unless explicitly stated as such, any information that you receive is not real-time.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
All content on the ETF Market Canada is for your general information use only, Cboe is not responsible for any use of content by you outside this scope. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cboe and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.